PL2032163T3 - Wielodawkowa szczepionka przeciwko grypie o małej zawartości adiuwanta - Google Patents

Wielodawkowa szczepionka przeciwko grypie o małej zawartości adiuwanta

Info

Publication number
PL2032163T3
PL2032163T3 PL07804945T PL07804945T PL2032163T3 PL 2032163 T3 PL2032163 T3 PL 2032163T3 PL 07804945 T PL07804945 T PL 07804945T PL 07804945 T PL07804945 T PL 07804945T PL 2032163 T3 PL2032163 T3 PL 2032163T3
Authority
PL
Poland
Prior art keywords
sparing
adjuvant
vaccination regimen
influenza vaccination
dose influenza
Prior art date
Application number
PL07804945T
Other languages
English (en)
Inventor
Giudice Giuseppe Del
Riccardo Manetti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38832174&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2032163(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2032163T3 publication Critical patent/PL2032163T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
PL07804945T 2006-06-15 2007-06-15 Wielodawkowa szczepionka przeciwko grypie o małej zawartości adiuwanta PL2032163T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81466506P 2006-06-15 2006-06-15
PCT/IB2007/002724 WO2007144772A2 (en) 2006-06-15 2007-06-15 Adjuvant-sparing multi-dose influenza vaccination regimen
EP07804945A EP2032163B1 (en) 2006-06-15 2007-06-15 Adjuvant-sparing multi-dose influenza vaccination regimen

Publications (1)

Publication Number Publication Date
PL2032163T3 true PL2032163T3 (pl) 2013-06-28

Family

ID=38832174

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07804945T PL2032163T3 (pl) 2006-06-15 2007-06-15 Wielodawkowa szczepionka przeciwko grypie o małej zawartości adiuwanta

Country Status (18)

Country Link
US (3) US20090220545A1 (pl)
EP (1) EP2032163B1 (pl)
JP (2) JP5566687B2 (pl)
KR (1) KR20090016704A (pl)
CN (1) CN101500603A (pl)
AU (1) AU2007258874B2 (pl)
BR (1) BRPI0713150A8 (pl)
CA (1) CA2657989A1 (pl)
CY (1) CY1114315T1 (pl)
DK (1) DK2032163T3 (pl)
EA (1) EA017441B1 (pl)
ES (1) ES2401484T3 (pl)
HK (1) HK1129205A1 (pl)
PL (1) PL2032163T3 (pl)
PT (1) PT2032163E (pl)
SI (1) SI2032163T1 (pl)
WO (1) WO2007144772A2 (pl)
ZA (1) ZA200810582B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11707520B2 (en) 2005-11-03 2023-07-25 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
EP1945252B1 (en) * 2005-11-04 2013-05-29 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising purified surface antigens prepared from influenza viruses grown in cell culture, adjuvanted with squalene
JP5518041B2 (ja) * 2008-03-18 2014-06-11 ノバルティス アーゲー インフルエンザウイルスワクチン抗原の調製における改良
GB0905570D0 (en) * 2009-03-31 2009-05-13 Novartis Ag Combined vaccines
DK2396032T3 (en) 2009-02-10 2016-12-19 Seqirus Uk Ltd Influenza vaccines with reduced amounts of squalene
KR101176305B1 (ko) * 2009-10-14 2012-08-23 웅진코웨이주식회사 붉나무 추출물을 포함하는 인플루엔자 바이러스 감염의 예방용 조성물, 상기 조성물을 포함하는 기상필터 및 상기 필터를 포함하는 공기청정기
US20110126501A1 (en) 2009-10-16 2011-06-02 Woongjin Coway Co., Ltd. Composition for prevention of influenza viral infection comprising tannic acid, air filter comprising the same and air cleaning device comprising the filter
KR101153630B1 (ko) * 2009-10-16 2012-06-18 웅진코웨이주식회사 타닌산을 포함하는 인플루엔자 바이러스 감염의 예방용 조성물, 상기 조성물을 포함하는 기상필터 및 상기 필터를 포함하는 공기청정기
WO2011102873A1 (en) * 2010-02-21 2011-08-25 Innovative Bottles, Llc Biodegradable pharmacy container and safety cap
JP5988435B2 (ja) * 2010-01-24 2016-09-07 ノバルティス アーゲー 放射線照射された生分解性微粒子
US8852157B2 (en) 2010-02-21 2014-10-07 Innovative Bottles, Llc Disposable items made from bioplastic resins
PL2569007T3 (pl) * 2010-05-11 2016-04-29 Intervet Int Bv Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki
RU2013144207A (ru) * 2011-03-02 2015-04-10 Новартис Аг Комбинированные вакцины с пониженными дозами антигена и/или адъюванта
CA2955456A1 (en) 2014-07-17 2016-01-21 Brian J. Czerniecki Identification of immunogenic mhc class ii peptides for immune-based therapy
EP3213786A4 (en) * 2014-10-30 2018-07-11 Chugai Seiyaku Kabushiki Kaisha Pre-filled syringe preparation with needle, which is equipped with syringe cap
SG11201706247VA (en) 2015-02-03 2017-08-30 Merz Pharma Gmbh & Co Kgaa Botulinum toxin prefilled container
EP3313439A2 (en) 2015-06-26 2018-05-02 Seqirus UK Limited Antigenically matched influenza vaccines
EP3325005A4 (en) * 2015-07-17 2019-03-27 Brian J. Czerniecki IDENTIFICATION OF IMMUNOGENIC CLASS II PEPTIDES OF THE MAJOR HISTOCOMPATIBILITY COMPLEX FOR IMMUNOTHERAPY
JP2021533157A (ja) * 2018-08-07 2021-12-02 ウィスコンシン アルムニ リサーチ ファンデイション 組換えの生物学的に封じ込められたフィロウイルスワクチン
WO2020163804A1 (en) 2019-02-08 2020-08-13 Wisconsin Alumni Research Foundation (Warf) Humanized cell line
US11807872B2 (en) 2019-08-27 2023-11-07 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001947A1 (en) 1988-08-25 1990-03-08 The Liposome Company, Inc. Affinity associated vaccine
AU631377B2 (en) * 1988-08-25 1992-11-26 Liposome Company, Inc., The Affinity associated vaccine
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
DE10012370A1 (de) * 2000-03-14 2001-09-27 Chiron Behring Gmbh & Co Adjuvans für Vakzinen
DE602004028468D1 (de) * 2003-06-17 2010-09-16 Mannkind Corp Haltung von immunantworten gegen mhc-klasse-i-beschränkte epitope, für prophylaktische oder therapeutische zwecke
EP1722815A1 (en) * 2004-03-09 2006-11-22 Chiron Corporation Influenza virus vaccines
PE20061428A1 (es) 2005-03-23 2007-01-16 Glaxosmithkline Biolog Sa Formulacion de vacuna que comprende un adyuvante de emulsion aceite en agua y 3d-mpl
US20100158943A1 (en) * 2005-11-04 2010-06-24 Novartis Vaccines And Diagnostics Srl Administration routes for priming/boosting with influenza vaccines
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
MX2009000660A (es) 2006-07-17 2009-04-08 Glaxosmithkline Biolog Sa Vacuna de influenza.

Also Published As

Publication number Publication date
US9901630B2 (en) 2018-02-27
HK1129205A1 (en) 2009-11-20
AU2007258874A1 (en) 2007-12-21
EA017441B1 (ru) 2012-12-28
US20090220545A1 (en) 2009-09-03
EP2032163B1 (en) 2013-01-23
KR20090016704A (ko) 2009-02-17
SI2032163T1 (sl) 2013-05-31
WO2007144772A2 (en) 2007-12-21
BRPI0713150A2 (pt) 2012-03-27
US20140370053A1 (en) 2014-12-18
EP2032163A2 (en) 2009-03-11
JP5981951B2 (ja) 2016-08-31
CN101500603A (zh) 2009-08-05
JP5566687B2 (ja) 2014-08-06
JP2009539965A (ja) 2009-11-19
ES2401484T3 (es) 2013-04-22
EA200970013A1 (ru) 2009-06-30
JP2014098038A (ja) 2014-05-29
CA2657989A1 (en) 2007-12-21
DK2032163T3 (da) 2013-03-25
CY1114315T1 (el) 2016-08-31
AU2007258874B2 (en) 2013-11-14
PT2032163E (pt) 2013-04-11
US8808686B2 (en) 2014-08-19
ZA200810582B (en) 2009-09-30
WO2007144772A3 (en) 2008-03-27
US20120039934A1 (en) 2012-02-16
BRPI0713150A8 (pt) 2017-08-22

Similar Documents

Publication Publication Date Title
ZA200810582B (en) Adjuvant-sparing multi-dose influenza vaccination regimen
IL196024A0 (en) Influenza vaccine
HK1143085A1 (en) Low-additive influenza vaccines
SI2422810T1 (sl) Influenčno cepivo
GB0607088D0 (en) Vaccine
GB0810305D0 (en) Influenza vaccination
EP1998814A4 (en) NEW VACCINES AGAINST INFLUENZA M2
ZA200809056B (en) Influenza virus vaccine
HK1129836A1 (zh) 疫苗
EP2318044A4 (en) INFLUENZA VACCINES
ZA200901592B (en) Vaccine
EP2240199A4 (en) INFLUENZA VACCINES
ZA200900062B (en) Influenza vaccine
GB0625593D0 (en) Vaccine
GB0625453D0 (en) Influenza vaccine
GB0623865D0 (en) Influenza vaccine
GB0623218D0 (en) Influenza vaccine
GB0619090D0 (en) Influenza vaccine
GB0618195D0 (en) Influenza vaccine
GB0723987D0 (en) Influenza vaccine reagents
GB0606256D0 (en) Anti-atheroma vaccine
GB0619822D0 (en) Vaccine
GB0620815D0 (en) Vaccine
GB0620816D0 (en) vaccine
GB0620336D0 (en) Vaccine